What Allena Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Brenner Louis Md | President and CEO | Nov 15 | Exercise / conversion · M | +125,582 | — | — | 328,904 |
| Brenner Louis Md | President and CEO | Nov 15 | Open-market sale · S | −40,328 | $0.81 | −$32.7K | 288,576 |
| Brenner Louis Md | President and COO | May 10 | Exercise / conversion · M | +83,721 | — | — | 228,537 |
| Brenner Louis Md | President and COO | May 10 | Open-market sale · S | −25,215 | $1.11 | −$28K | 203,322 |
| Wholihan Edward | Chief Financial Officer | Dec 17 | Exercise / conversion · M | +164,822 | — | — | 189,822 |
| Wholihan Edward | Chief Financial Officer | Dec 17 | Open-market sale · S | −68,550 | $1.36 | −$93.2K | 121,272 |
| Brenner Louis Md | President and CEO | Dec 17 | Exercise / conversion · M | +247,932 | — | — | 247,932 |
| Brenner Louis Md | President and CEO | Dec 17 | Open-market sale · S | −103,116 | $1.36 | −$140K | 144,816 |
| Wholihan Edward | Chief Financial Officer | May 09 | Exercise / conversion · M | +25,000 | $1.59 | +$39.8K | 25,000 |
| Bessemer Venture Partners Vii L.p. | 10% owner | Nov 06 | Open-market buy · P | +36,000 | $14.00 | +$504K | 2,263,365 |
| Bessemer Venture Partners Vii L.p. | 10% owner | Nov 06 | Derivative Conversion · C | +2,227,365 | — | — | 2,227,365 |
| Topper James N | Director | Nov 06 | Open-market buy · P | +500,000 | $14.00 | +$7M | 3,330,373 |
| Topper James N | Director | Nov 06 | Derivative Conversion · C | +254,409 | — | — | 2,830,373 |
| Topper James N | Director | Nov 06 | Derivative Conversion · C | +1,109,159 | — | — | 2,575,964 |
| Topper James N | Director | Nov 06 | Derivative Conversion · C | +1,466,805 | — | — | 1,466,805 |
| Kraus Stephen | Director | Nov 06 | Open-market buy · P | +0 | — | — | 0 |
| Kraus Stephen | Director | Nov 06 | Derivative Conversion · C | +0 | — | — | 0 |
| Third Rock Ventures II, L.p. | 10% owner | Nov 06 | Open-market buy · P | +215,000 | $14.00 | +$3.01M | 2,790,964 |
| Third Rock Ventures II, L.p. | 10% owner | Nov 06 | Derivative Conversion · C | +2,575,964 | — | — | 2,575,964 |
| Tepper Robert I | Director | Nov 06 | Open-market buy · P | +215,000 | $14.00 | +$3.01M | 2,790,964 |
Loading...
